By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CombiMatrix raised $6.7 million in a private placement, the company announced after the close of the market on Thursday.

The company had announced the securities purchase agreement earlier in the week, saying it sought to sell nearly $6.8 million in newly issued shares of its common stock and warrants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.